In preparation for this workshop, the Steering Committee charged the presenters and discussants with identifying articles that would provide a context to the workshop’s discussion. The following articles were submitted and are linked to their PubMed.gov record.
Barlow DH, Gorman JM, Shear MK, Woods SW: Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Journal of the American Medical Association. 2000 May 17; 283(19): 2529–2536.
Brigham GS, Feaster DJ, Wakim PG, Dempsey CL: Choosing a control group in effectiveness trials of behavioral drug abuse treatments. Journal of Substance Abuse Treatment. 2009 Dec; 37(4): 388–397.
Elkin I, Gibbons RD, Shea MT, Sotsky SM, Watkins JT, Pilkonis PA, Hedeker D: Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology. 1995 Oct; 63(5): 841–847.
Finniss DG, Kaptchuk TJ, Miller F, Benedetti F: Biological, clinical, and ethical advances of placebo effects. Lancet. 2010 February 20; 375(9715): 686–695.
Horng SH, Miller FG: Placebo controlled procedural trials for neurological conditions. Neurotherapeutics. 2007 Jul; 4(3): 531–536.
Hrobjartsson A & Miller FG: Placebo control groups in non-pharmacological randomized trials in Randomized Clinical Trials of Nonpharmacologic Treatment, edited by Boutron I, Ravaud P, Moher D. (in press)Chapman & Hall.
Kaptchuk TJ, Kerr CE, Zanger A: The art of medicine: Placebo controls, exorcisms, and the devil. Lancet. 2009 Oct 10; 374(9697): 1234–1235.
Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN, Nam BH, Nguyen LT, Park M, Rivers AL, McManus C, Kokkotou E, Drossman DA, Goldman P, Lembo AJ: Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. British Medical Journal. 2008 May 3; 336(7651): 999–1003.
Klein DF: Control groups in pharmacotherapy and psychotherapy evaluations. Treatment. 1997 Sept; 1(1): ArtID 1a.
Langevin HM, Hammerschlag R, Lao L, Napadow V, Schnyer RN, Sherman KJ: Controversies in acupuncture research: Selection of controls and outcome measures in acupuncture clinical trials. Journal of Alternative and Complementary Medicine. 2006 Dec; 12(10): 943–953.
Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, Ockene J, Kaplan R: The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics. 2009; 78: 275–284.
Nunes EV, Ball S, Booth R, Brigham G, Calsyn DA, Carroll K, Feaster DJ, Hien D, Hubbard RL, Ling W, Petry NM, Rotrosen J, Selzer J, Stitzer M, Tross S, Wakim P, Winhusen T, Woody G: Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs? Journal of Substance Abuse Treatment. 2010 Jun; 38(Suppl 1): S97–S112.
Penzien DB, Andrasik F, Freidenberg BM, Houle TT, Lake AE 3rd, Lipchik GL, Holroyd KA, Lipton RB, McCrory DC, Nash JM, Nicholson RA, Powers SW, Rains JC, Wittrock DA, American Headache Society Behavioral Clinical Trials Workgroup: Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup. Headache. 2005 May; 45(Suppl 2): S110-S132.
Vickers AJ: Placebo controls in randomized trials of acupuncture. Evaluation & the Health Professions. 2002 Dec; 25(4): 421–435.